| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,119 | 25,649 | 16,329 | 24,065 | | Cost of Revenue | 500 | 123 | 358 | 2,082 | | | Gross Profit | 19,619 | 25,526 | 15,971 | 21,983 | | | Operating Expenses | | Research Development | 9,828 | 6,427 | 5,832 | 2,902 | | Selling General and Administrative | 5,827 | 4,981 | 4,553 | 6,838 | | Non Recurring |
-
|
-
|
-
| (153) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,964 | 14,118 | 5,586 | 12,396 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 334 | 299 | (1,645) | (4,480) | | Earnings Before Interest And Taxes | 4,298 | 14,417 | 3,941 | 7,916 | | Interest Expense | 12,099 | 11,800 | 15,691 | 16,352 | | Income Before Tax | (7,801) | 2,617 | (11,750) | (8,436) | | Income Tax Expense | (35) |
-
| (1,014) | 41 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,766) | 2,617 | (10,736) | (8,477) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,766) | 2,617 | (10,736) | (8,477) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,766) | $2,617 | ($10,736) | ($8,477) |
|
0.02% Nasdaq 
0.33%
Income Statement
